Pixyl (Pixyl.Neuro) is a highly legitimate, FDA-cleared, and CE-marked AI solution for neuroimaging, recently acquired by Gleamer (2025). The project demonstrates exceptional real-world utility and technical innovation in the medical field. However, the submission form itself was of extremely poor quality, containing false claims ('everyone', 'most people') and vague data, which necessitates a significant penalty in the Response Quality and Randomization factors despite the project's proven success.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline